These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15558238)

  • 21. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial.
    Kanis JA; Johnell O; Black DM; Downs RW; Sarkar S; Fuerst T; Secrest RJ; Pavo I
    Bone; 2003 Sep; 33(3):293-300. PubMed ID: 13678769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of osteoporosis-associated vertebral fractures on health-related quality of life in the Mexican population.
    Ramírez-Pérez E; Clark P; Deleze M; Cons-Molina F; Morales-Torres J; Diez-García P
    Rev Invest Clin; 2014; 66(3):225-33. PubMed ID: 25695238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of health-related quality of life measures to predict health utility in postmenopausal osteoporotic women: results from the Multiple Outcomes of Raloxifene Evaluation study.
    Burge R; Shen W; Naegeli AN; Alam J; Silverman S; Gold DT; Shih T
    Health Qual Life Outcomes; 2013 Nov; 11():189. PubMed ID: 24192207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychometric properties of the osteoporosis assessment questionnaire (OPAQ) 2.0: results from the multiple outcomes of raloxifene evaluation (MORE) study.
    Shen W; Burge R; Naegeli AN; Shih J; Alam J; Gold DT; Silverman S
    BMC Musculoskelet Disord; 2014 Nov; 15():374. PubMed ID: 25403238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.
    Salaffi F; Malavolta N; Cimmino MA; Di Matteo L; Scendoni P; Carotti M; Stancati A; Mulé R; Frigato M; Gutierrez M; Grassi W;
    Clin Exp Rheumatol; 2007; 25(3):390-403. PubMed ID: 17631735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis.
    Felsenberg D; Miller P; Armbrecht G; Wilson K; Schimmer RC; Papapoulos SE
    Bone; 2005 Nov; 37(5):651-4. PubMed ID: 16126016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective assessment of thoracic kyphosis in postmenopausal women with osteoporosis.
    Roux C; Fechtenbaum J; Kolta S; Said-Nahal R; Briot K; Benhamou CL
    J Bone Miner Res; 2010 Feb; 25(2):362-8. PubMed ID: 19594302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline characteristics of the population enrolled in the Italian Observational Study on Severe Osteoporosis (ISSO).
    Adami S; Maugeri D; Toscano V; Topa G; Carminiti M; Brancati A; Massarotti M; Osella G; Malavolta N; Iolascon G; Cagnoni C; Camozzi V; Corradini C; Nardi A; Migliaccio S; Ulivieri FM; Resmini G; Valle D; Tauchmanovà L; Silvestri S;
    Clin Exp Rheumatol; 2011; 29(3):477-84. PubMed ID: 21640043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.
    Sarkar S; Mitlak BH; Wong M; Stock JL; Black DM; Harper KD
    J Bone Miner Res; 2002 Jan; 17(1):1-10. PubMed ID: 11771654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raloxifene reduces vertebral fracture risk in postmenopausal women with osteoporosis.
    Brandi ML
    Clin Exp Rheumatol; 2000; 18(3):309-10. PubMed ID: 10895366
    [No Abstract]   [Full Text] [Related]  

  • 31. Quality of life in osteoporotic women with inadequate clinical response to antiresorptive drugs: results from the ICARO study.
    Barbagallo M; Dominguez LJ; Maugeri D; Isaia G; Silvestri S; Bevilacqua M; Adami S;
    Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):24-7. PubMed ID: 18180604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the functioning of women with osteoporosis with vertebral fractures and without vertebral fractures using the Polish version of Qualeffo-41].
    Baczyk G; Opala T; Klejewski A; Tesarska B
    Chir Narzadow Ruchu Ortop Pol; 2010; 75(3):172-7. PubMed ID: 21038636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-vertebral fracture efficacy of raloxifene: a meta-analysis.
    Seeman E; Crans GG; Diez-Perez A; Pinette KV; Delmas PD
    Osteoporos Int; 2006 Feb; 17(2):313-6. PubMed ID: 16217588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trial.
    Qu Y; Wong M; Thiebaud D; Stock JL
    Curr Med Res Opin; 2005 Dec; 21(12):1955-9. PubMed ID: 16368046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial.
    Delmas PD; Ensrud KE; Adachi JD; Harper KD; Sarkar S; Gennari C; Reginster JY; Pols HA; Recker RR; Harris ST; Wu W; Genant HK; Black DM; Eastell R;
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3609-17. PubMed ID: 12161484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life after osteoporotic fractures.
    Hallberg I; Rosenqvist AM; Kartous L; Löfman O; Wahlström O; Toss G
    Osteoporos Int; 2004 Oct; 15(10):834-41. PubMed ID: 15045468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
    Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
    Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between health-related quality of life, physical function and pain in older women with osteoporosis and vertebral fracture.
    Stanghelle B; Bentzen H; Giangregorio L; Pripp AH; Bergland A
    BMC Geriatr; 2019 Nov; 19(1):298. PubMed ID: 31684886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal women.
    Fechtenbaum J; Cropet C; Kolta S; Horlait S; Orcel P; Roux C
    Osteoporos Int; 2005 Dec; 16(12):2175-9. PubMed ID: 16220230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between generic and disease-specific quality of life questionnaires and mobility and balance among women with osteoporosis and vertebral fractures.
    Bergland A; Thorsen H; Kåresen R
    Aging Clin Exp Res; 2011 Aug; 23(4):296-303. PubMed ID: 22067372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.